FSSKX
Price
$105.77
Change
-$0.94 (-0.88%)
Updated
Aug 20 closing price
Net Assets
10.98B
RGAFX
Price
$88.15
Change
+$0.79 (+0.90%)
Updated
Aug 21 closing price
Net Assets
342.42B
Interact to see
Advertisement

FSSKX vs RGAFX

FSSKX vs RGAFX Comparison Chart in %
View a ticker or compare two or three
VS
FSSKX vs. RGAFX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSKX is a StrongBuy and RGAFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 342B vs. FSSKX (11B). RGAFX pays higher dividends than FSSKX: RGAFX (0.48) vs FSSKX (0.45). FSSKX was incepted earlier than RGAFX: FSSKX (18 years) vs RGAFX (24 years). FSSKX (0.42) is less costly to investors than RGAFX (0.34). RGAFX is a more actively managed with annual turnover of: 32.00 vs. FSSKX (13.00). FSSKX has a lower initial minimum investment than RGAFX: FSSKX (0) vs RGAFX (250). FSSKX annual gain was more profitable for investors over the last year : 24.12 vs. RGAFX (5.92). FSSKX return over 5 years is better than : 63.61 vs. RGAFX (18.79).
FSSKXRGAFXFSSKX / RGAFX
Total Expense Ratio0.420.34124%
Annual Report Gross Expense Ratio0.420.34124%
Fund Existence18 years24 years-
Gain YTD17.8509.612186%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets11B342B3%
Annual Yield % from dividends0.450.4895%
Returns for 1 year24.125.92408%
Returns for 3 years69.0448.73142%
Returns for 5 years63.6118.79338%
Returns for 10 years204.41104.75195%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWFX109.531.63
+1.51%
American Funds New World R-5
CMJAX52.540.36
+0.69%
Calvert US Mid Cap Core Rspnb Idx A
SVFDX100.610.67
+0.67%
Smead Value R1
PSSMX31.230.20
+0.64%
Principal SmallCap S&P 600 Index R3
CREYX11.05N/A
N/A
Columbia Real Estate Equity Inst3